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’INTRODUCTION
trans-4-Hydroxynonenal (HNE) is produced from the meta-
bolism of membrane lipids.
1 It is also the major peroxidation
product of ω-6 polyunsaturated fatty acids in vivo.
2,3 Several
routes for the formation of HNE from ω-6 polyunsaturated fatty
acids have been described.
4 6HNEexhibitsa range of biological
eﬀects, from alteration in gene expression and cell signaling to
cell proliferation and apoptosis.
7 13 HNE is implicated in the
etiologiesofanumberofdiseasesassociatedwithoxidativestress,
includingAlzheimer’sdisease,
14Parkinson’sdisease,
15arteriosclerosis,
16
and hepatic ischemia reperfusion injury.
17
HNE induces the SOS response in Escherichia coli, suggesting
that it is also genotoxic.
18 Chromosomal aberrations have been
observeduponexposurestoHNEinmammalian,includinghuman,
cells.
19 23Inmammaliancells,thegenotoxicityofHNEdepends
upon glutathione levels, which modulate levels of HNE-DNA
adducts.
24 26MichaeladditionoftheN
2-aminogroupof20-deo-
xyguanosine to HNE gives four diastereomeric 1,N
2-dG adducts
1 4,
27 29 which have been detected in cells.
30 36 Alternatively,
oxidation of HNE to 2,3-epoxy-4-hydroxynonanal, and further
reaction with nucleobases, aﬀords etheno adducts.
37 41
Wang et al.
42,43 synthesized the four stereoisomers of the
1,N
2-dG adduct (1 4, Chart 1) and incorporated them into
50-d(GCTAGCZAGTCC)-30
350-d(GGACTCGCTAGC)-30,i n
whichZdenotestheHNE-dGadduct.Ofthefourdiastereomeric
adducts,only(6S,8R,11S) diastereomer1formsinterstrandcross-
links in the 50-CpG-30 sequence. At equilibrium, cross-linking by
diastereomer 1 reached >85%.
43 However, it required several
months to attain equilibrium at 37 C.
43 The discovery that
whenplacedintoDNAdiastereomeric HNE-dGadducts1and3
rearrange to the cyclic hemiacetals provided a rationale for the
slow rate of cross-link formation.
44 The hemiacetal eﬀectively
masks the reactive aldehyde necessary for cross-link formation.
The major cyclic hemiacetal rearrangement products from
HNE-dG adducts 1 and 3 were subsequently examined as to
structure in this duplex.
45 Both oriented in the minor groove of
DNA. However, the cyclic hemiacetal rearranged from adduct 1
oriented in the 50-direction, while the cyclic hemiacetal rear-
ranged fromadduct3orientedinthe30-direction.
45,46Molecular
mechanics calculations predicted that the N
2-dG aldehyde having
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ABSTRACT: Michael addition of trans-4-hydroxynonenal
(HNE) to deoxyguanosine yields diastereomeric 1,N
2-dG ad-
ducts in DNA. When placed opposite dC in the 50-CpG-30
sequence, the (6S,8R,11S) diastereomer forms a N
2-dG:N
2-dG
interstrand cross-link [Wang, H.; Kozekov, I. D.; Harris, T. M.;
Rizzo, C. J. J. Am. Chem. Soc. 2003, 125, 5687 5700]. We
reﬁned its structure in 50-d(G
1C
2T
3A
4G
5C
6X
7A
8G
9T
10C
11C
12)-
30
350-d(G
13G
14A
15C
16T
17C
18Y
19C
20T
21A
22G
23C
24)-30 [X
7 is
thedGadjacenttotheC6carbonofthecross-linkortheR-carbonofthe(6S,8R,11S)1,N
2-dGadduct,andY
19isthedGadjacentto
the C8 carbon of the cross-linkor the γ-carbon of the HNE-derived(6S,8R,11S)1 , N
2-dG adduct;the cross-linkis inthe 50-CpG-30
sequence]. Introduction of
13C at the C8 carbon of the cross-link revealed one
13C8fH8 correlation, indicating that the cross-link
existed predominantly as a carbinolamine linkage. The H8 proton exhibited NOEs to Y
19 H10,C
20 H10, and C
20 H40, orienting it
toward the complementary strand, consistent with the (6S,8R,11S) conﬁguration. An NOE was also observed between the HNE
H11 proton and Y
19 H10, orienting the former toward the complementary strand. Imine and pyrimidopurinone linkages were
excluded by observation of the Y
19 N
2H and X
7 N1H protons, respectively. A strong H8fH11 NOE and no
3J(
13CfH) coupling
for the
13C8 O C11 H11 eliminated the tetrahydrofuran species derived from the (6S,8R,11S)1 , N
2-dG adduct. The
(6S,8R,11S) carbinolamine linkage and the HNE side chain were located in the minor groove. The X
7 N
2 and Y
19 N
2 atoms
were in the gauche conformation with respect to the linkage, maintaining Watson Crick hydrogen bonds at the cross-linked base
pairs.AsolvatedmoleculardynamicssimulationindicatedthattheanticonformationofthehydroxylgroupwithrespecttoC6ofthe
tether minimized steric interaction and predicted hydrogen bonds involving O8H with C
20 O
2 of the 50-neighbor base pair G
5
3C
20
andO11HwithC
18O
2ofX
7
3C
18.Thesemay,inpart,explainthestabilityofthiscross-linkandthestereochemicalpreferenceforthe
(6S,8R,11S) conﬁguration.16102 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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6R conﬁguration oriented in the 30-direction, while the N
2-dG
aldehyde having 6S conﬁguration oriented in the 50-direction.
45,46
These diﬀerences suggesteda kinetic basis to explain, in part, the
relative abilities of the (6S,8R,11S) and (6R,8S,11R) diastereo-
meric adducts 1 and 3 to form cross-links in the 50-CpG-30
sequence (Schemes 1 and 2).
43
In the present work, the structure of this cross-link has been
reﬁned in 50-d(G
1C
2T
3A
4G
5C
6X
7A
8G
9T
10C
11C
12)-30
350-d-
(G
13G
14A
15C
16T
17C
18Y
19C
20T
21A
22G
23C
24)-30 [X
7 is the dG
adjacent to the C6 carbon of the cross-link (the R-carbon of the
HNE-derived (6S,8R,11S)1 , N
2-dG adduct 1), and Y
19 is the dG
adjacent to the C8 carbon of the cross-link (the γ-carbon of the
HNE-derived(6S,8R,11S)1,N
2-dGadduct1);thecross-linkisin
the 50-CpG-30 sequence].
13C HSQC NMR reveals one
13C8fH8
correlation, indicating that the cross-link exists predominantly as
asinglespecies,identiﬁedasa(6S,8R,11S)carbinolaminelinkage
8.NOEdataindicatethatthe(6S,8R,11S)carbinolaminelinkage
8 and the HNE moiety are oriented in the minor groove. The X
7
N
2andY
19N
2atomsareinthegauche-conformationwithrespectto
the linkage, maintaining Watson Crick hydrogen bonds at the
cross-linkedbasepairs.Solvatedmoleculardynamicssimulations
indicate that the anti conformation of the hydroxyl group with
respect to C6 of the tether minimizes steric interaction and
predictahydrogenbondbetweenthehydroxylgroupandC
20O
2
of the 50-neighbor base pair G
5
3C
20. As well, the C11 hydroxyl
predominantly formed a hydrogen bond with C
18 O
2. These
hydrogen bonds may, in part, explain the stability of this cross-
link and the preference for the (6S,8R,11S) conﬁguration 8.
’RESULTS
Formation of the Cross-link. The oligodeoxynucleotide 50-
d(GCTAGCZAGTCC)-30 [Z=( 6 S,8R,11S) HNE adduct 1]
was annealed with the complementary strand 50-d(GGACT-
CGCTAGC)-30 at pH 7.0. The duplex was maintained at 37 C
for 3 months at pH 7.3. This afforded the N
2-dG:N
2-dG cross-
link, as reported.
43 The presence of the cross-link was confirmed
Chart 1
Scheme 1. Formation of the N
2-dG:N
2-dG Cross-link by the Oligodeoxynucleotide Duplex Containing the HNE Adduct 1 in the
50-CpG-30 Sequence16103 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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by reverse-phase HPLC analysis (Figure S1 in the Supporting
Information). The cross-link was also characterized by MALDI-TOF
mass spectrometry, which showed the cross-link at m/z of 7428.2
[calculatedforiminecross-link10(M 1):7429.0] (FigureS2inthe
Supporting Information). The intensities of the cytosine H5 H6
NMR scalar couplings were used to evaluate the extent of the DNA
cross-linking reaction (Figure S3 in the Supporting Information).
HPLC analysis suggested the duplex was >75% cross-linked.
NMR Resonance Assignments.The cross-linked sample was
used for NMR experiments without further purification. The
spectra were of high quality and suitable for structural analysis.
The assignments of the nonexchangeable protons of the nucleo-
tides were accomplished using standard protocols.
47,48 For the
50-d(G
1C
2T
3A
4G
5C
6X
7A
8G
9T
10C
11C
12)-30 strand,completeNOE
connectivity was observed between the aromatic and anomeric
protons(FigureS4intheSupportingInformation).Asmallcross
peak was assigned to the C
6 H10fX
7 H8 correlation. Complete
NOE connectivity was also observed for the 50-d(G
13G
14A
15-
C
16T
17C
18Y
19C
20T
21A
22G
23C
24)-30 strand. With the exceptions
of several of the H40 protons, and the stereotopic assignments of
theH50 andH500 sugarprotons,allother assignmentsweremade
unequivocally. In general, canonical B-DNA distances between
theH40,H5 0,andH500 protonswereusedtotentativelyassignthe
H50 and H500 deoxyribose protons. The chemical shifts of the
nonexchangeable DNA protons are collected in Table S1 of the
Supporting Information. As compared to the corresponding
unmodified duplex, remarkable changes in chemical shifts were
observed for protons located in the cross-linked region, suggest-
ing perturbation of the cross-linked and the flanking base pairs
(Figure S5 in the Supporting Information).
The imino proton resonances of Watson Crick base paired
guanines and thymines were also assigned following standard
protocols.
49 The imino proton resonances were observed for all
guanines and thymines, and a complete NOE connectivity was
obtained, with the exceptions of the terminal guanines G
1 and
G
13, the resonances of which were broadened by solvent exchange
(Figure S6 in the Supporting Information). The X
7 N1HfC
18
N
4H(s) and Y
19 N1HfC
6 N
4H(s) NOEs were observed, indicat-
ing the presence of the C
6
3Y
19 and X
7
3C
18 pairs at the cross-
linked site. Strong X
7 N1HfX
7 N
2H and Y
19 N1HfY
19 N
2H
NOEs were observed, also consistent with Watson Crick base
pairing at the cross-linked site. The X
7 N1HfA
8 H2 NOE was
also observed, consistent with the intrahelical stacking of the
modiﬁed nucleotide X
7.
The assignments of HNE protons were made by a combina-
tion of
1H 
1H NOESY (60 ms) (Figure 1),
1H 
1H DQF-
COSY, and
1H 
1HTOCSYexperiments.The HNEH6andH8
protons were assigned by inspection of the H6fX
7 N
2H and
H8fY
19 N
2H NOEs. Both of these protons exhibited scalar and
dipolar coupling with the geminal HNE H7 protons. H6 also
exhibited scalar and dipolar coupling with H11. H11 exhibited
scalar and dipolar coupling with the geminal H12 protons. The
protons in the HNE side-chain were partially assigned sequen-
tially based on the scalar and dipolar couplings from H12f
H13fH14fH15fH16. The geminal H7 and H11 protons ex-
hibited strong scalar and dipolar couplings. The absolute
conﬁgurations of the geminal H7 protons were determined
by their NOEs with H8. H7β,w h i c hw a si nt h et r a n sc o n ﬁg-
uration with respect to H8, showed a smaller dipolar coupling
with H8 than did H7R. The stereotopic assignments of the
geminal H12 protons could not be unequivocally determined.
The intensities of the H11fH12R and H11fH12β NOEs
appeared equal, indicating H11 was in the gauche conforma-
tionwithrespecttobothprotons.AnumberofNOEsbetween
theseHNE protonsand the DNA protonsX
7 N1H, X
7 N
2H,Y
19
N1H, and Y
19 N
2H were observed. The chemical shifts of the
HNE protons and the NOEs used for the rMD calculations are
listed in Table 1.
Figure 1. Expansions of the
1H 
1H NOESY spectrum obtained at a
mixing time of 60 ms of the cross-link showing the assignments of some
HNE protons. The strong H8fH11 NOE (peak a) implies the cross-
link exists as carbinolamine 8.
Scheme 2. (A)NumberingSchemeoftheDuplexContaining
(6S,8R,11S)1 , N
2-dG Adduct 1;
a,b and (B) Numbering
Scheme of the (6S,8R,11S) Carbinolamine Cross-link 8
a,c,d
aThe
13Clabeledcarbonisinred.
bZ
7representstheHNEadduct1.
cX
7
and Y
19 represent the N
2-cross-linked deoxyguanosines; the atoms are
numbered as for deoxyguanosine.
dThe atom numbers of the HNE
linkage are consistent with those in the HNE adduct 1.16104 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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Identification of the Cross-link. The introduction of
13Ca t
the γ carbon of HNE adduct 1 enabled the chemistry of cross-
linking to be monitored, in situ. Figure 2 displays the
1H 
13C
HSQC and
1H 
13C HMBC spectra of the sample before and
after cross-linking. The
1H 
13C HSQC spectrum of the
13C-
labeled sample exhibited a strong C8fH8 correlation (Figure 2),
indicating that only one cross-link species was produced. Of the
fourpotentialspeciesforthecross-link(Scheme1),imine10and
pyrimidopurinone 12 were excluded as the observed cross-links
bytheobservationofY
19N
2HandX
7N1Hprotons,respectively.
The cyclic hemiacetal 6 derived from HNE adduct 1 contains a
THF unit and exhibited a
3J(
13CfH) coupling for the C8 O 
C11 H11. The cross-link did not exhibit this correlation. The
cross-link exhibited NOE correlations for H8 with Y
19 H10,C
20
H10, and C
20 H40 (Figure 3), suggesting H8 oriented toward
the complementary strand. The cross-link also exhibited the
H11fY
19 H10 NOE, suggesting that H11 oriented in the same
direction toward the complementary strand. A strong H8fH11
NOE was observed (Figure 1). Molecular modeling indicated
that the THF cross-link 11 placed the H8 and H11 in the trans
configuration, with H11 oriented toward the 50-d(G
1C
2T
3A
4G
5-
C
6X
7A
8G
9T
10C
11C
12)-30 strand, such that a strong H8fH11
NOE correlation was not possible (Figure S7 in the Support-
ing Information). In contrast, the carbinolamine cross-link
could place both H8 and H11 toward the complementary
strand with a distanceoflessthan 3Å. Therefore, thecross-link
derived from the (6S,8R,11S) HNE-dG adduct 1 existed as
carbinolamine 8 or 9.
Stereochemistry of the Cross-link. Formation of a carbino-
lamine cross-link from the N
2-dG aldehydic adduct 5 creates a
chiral center at C8 (Chart 2). The orientation of H8 toward
the complementary strand indicated the R-configuration at the
C8position. Thus,theN
2-dG:N
2-dGcross-linkderivedfromthe
(6S,8R,11S) HNE-dG adduct 1 existed as (6S,8R,11S) carbino-
lamine 8.
Stability of the Cross-link. The resonances of thymine N3H
and guanine N1H imino protons at different temperatures are
shown in Figure 4. The melting temperature Tm of the cross-link
was >90 C in 1 M NaCl buffer, confirming previous measurements.
43
Table 1. Chemical Shifts of the HNE Protons and NOEs Used for rMD Calculations.
a
proton δ (ppm) NOE
H6 3.47 H7R (s); H7β (s); H8 (m); H12R (s); H12β (s); X
7 H10 (w); A
8 H10 (w); A
8 H2 (w); A
8 H40 (w)
H7R 1.57 H8 (s); A
8 H10 (w)
H7β 2.15 H8 (s); H11 (w); H12R (m); A
8 H10 (w)
H8 5.74 H11 (s); H12R (s); H12β (s); Y
19 H10 (w); C
20 H10 (m); C
20 H40 (m)
H11 3.61 H12R (s); H12β (s)
H12R 1.29 A
8 H40 (m); G
9 H40 (m)
H12β 1.56 H16 (m); A
8 H40 (m); G
9 H40 (w); Y
19 H40 (m); C
20 H40 (m); C
20 H50 (m)
H13 1.21 X
7 H40 (m); C
20 H40 (m)
H14 1.34 H16 (m); X
7 H40 (m); Y
19 H40 (m); C
20 H40 (m); C
20 H50 (m)
H15 1.28 H16 (s); X
7 H40 (m); G
9 H40 (m)
H16 0.85 X
7 H40 (m); G
9 H40 (w); Y
19 H40 (w); C
20 H40 (m); C
20 H50 (m)
aLetters in brackets indicate peak intensity: s, strong; m, medium; w, weak.
Figure 2.
1H 
13C HSQC and
1H 
13C HMBC spectra of the
13C-labeled duplex. (A)
1H 
13C HSQC before cross-linking; peaks are designated
(a)H8fC8ofcyclichemiacetal6and(b)H8fC8ofcyclichemiacetal7.(B)
1H 
13CHMBCbeforecross-linking;peaksaredesignated(c)H6fC8,
(d) H11fC8, (e) H7fC8 of cyclic hemiacetal 6, (f) H7fC8 of cyclic hemiacetal 7. (C)
1H 
13C HSQC after cross-linking; peak is designated
(g) H8fC8 of the cross-link 8. (D)
1H 
13C HMBC after cross-linking; peaks are designated (h) H6fC8,(i) H7βfC8,(j) H7RfC8 ofcross-link 8.
Figure 3. Expansions of the
1H 
1H NOESY spectrum obtained at a
mixing time of 250 ms of the cross-link. NOEs used to determine the
conﬁgurationofC8areassignedas(a)Y
19H10fH8;(b)C
20H10fH8;
and (c) H8fC
20 H40.16105 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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Consistent with the high melting temperature, the X
7 and Y
19
imino resonances remained sharp at 55 C. For the 50-neighbor
base pair G
5
3C
20, the G
5 imino resonance also remained sharp
at 55 C, albeit more broadened than the X
7 and Y
19 imino
resonances. In contrast, other guanine N1H protons were not
observed at 55 C. At the 30-neighbor A
8
3T
17 base pair, the T
17
imino resonance was broadened at 45 C and not observed at
55 C. This was comparable with the other thymine N3H protons.
Thisindicatedthatthecross-linkedand50-neighborG
5
3C
20base
pairs were stabilized by the cross-linking, whereas the 30-neighbor
A
8
3T
17 base pair was not affected.
Structural Refinement. The structural refinement involved
372 distance restraints, including 203 intranucleotide and 169
internucleotide restraints, which were obtained from the intensities
of NOE cross peaks. In addition, 52 empirical distance restraints
defining Watson Crick base pairing were used to refine the
structureof theduplex; theirusewas predicated uponinspection
of the NMR data, which indicated that Watson Crick base
pairing was intact throughout the duplex. Finally, an additional
180 empirical backbone torsion angle restraints were also used
forstructurerefinement;thesewerebaseduponinspectionofthe
NMRdata,whichsuggestedthattheadductedduplexmaintained
a B-family architecture. The NOE restraints used for the structural
refinement are listed in Table S2 in the Supporting Information.
The randomly seeded rMD calculations were performed starting
with initial structures, which were created either with A- or with
B-form conformations.
50 The force ﬁeld parameters used for the
cross-link are provided in Figure S8 of the Supporting Informa-
tion. Pairwise rmsd analysis of emergent structures indicated
that the calculations converged, irrespective of starting structure
(Table2).Theaccuraciesoftheemergentstructureswereevaluated
by comparison of theoretical NOE intensities calculated by com-
plete relaxation analysis
51 of the reﬁned structure, to the experi-
mental NOE intensities, to yield sixth root residuals (R1
x).
52,53
Thisresidualwaslessthan0.1forthemodiﬁedduplex(Table2),
andtheinter-andintranucleotideresidualsforindividualnucleo-
tides were less than 0.15, indicating that the reﬁned structures
provided an accurate depiction of the NOE data. The residue-
by-residue R1
x values are shown in Figure S9 of the Supporting
Information.
Structure of the Cross-link. The refined structure of the
(6S,8R,11S) carbinolamine cross-link maintained B-family DNA
conformation (Figure S10 of the Supporting Information). All
nucleotides maintained the anti conformation about the glycosyl
torsion angles. The deoxyribose pseudorotations were consistently
either C10-exo or C20-endo. The helicoidal analysis of the back-
bone torsion angles of the refined structure is shown in Figure
S11 of the Supporting Information. Perturbations of ζ angle
(C30 O30 P O50)wereobserved atcross-linkedbases X
7and
Y
19. This is consistent with the observation of two downfield
shifted
31P resonances (Figure S12 of theSupporting Information).
An expanded view from the minor groove at the cross-linked
region is displayed in Figure 5. A perturbation was observed for
the cross-linked and the 30-neighbor A
8
3T
17 base pairs, whereas
no perturbation was observed for the 50-neighbor G
5
3C
20 base
pair.Figure6showsthebasepairingofthecross-linkedandflanking
base pairs.
The3-carbon linkageof thecross-link was folded inthe minor
groove. Figure 7 demonstrates the conformation of the linkage
andtheNewmanprojectionsviewedalongtheC6 C7,C7 C8,
and C6 C11 bonds. Both X
7 N
2 and Y
19 N
2were inthe gauche-
conformation with respect to C6 and C8, respectively, which
facilitated the Watson Crick hydrogen bonding of the C
6
3Y
19
Figure 4.
1H NMR of the imino proton region of the cross-linked duplex
as a function of temperature.
Table 2. rMD Restraints and Statistical Analysis of rMD
Structures of the Cross-link
total restraints used for rMD calculation 604
experimental NOE distance restraints
a 372
intraresidue NOE restraints 203
inter-residue NOE restraints 169
NOE restraints for HNE linkage 46
base pairing distance restraints 52
backbone torsion angle restraints 100
sugar puckering restraints 80
structural analysis
NMR R-factor (R1
x)(  10
 2)
b 8.4
intraresidue 7.6
inter-residue 9.7
rmsd deviation of reﬁned structures (Å) 0.48
aHNEunitwasconsideredtobeasingleresidueattachedtoguaninesX
7
and Y
19 in the rMD calculations and the statistical analyses.
bMixing
timeused tocalculate R1
xwas250 ms.R1
x =∑|(a0)i
1/6 (ac)i
1/6|/|(a0)i
1/
6|, where (a0) and (ac) are the intensities of observed (nonzero) and
calculated NOE cross peaks, respectively.
Chart 2. Structures of the (6S,8R,11S) and (6S,8S,11S)
Carbinolamine Cross-links16106 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
Journal of the American Chemical Society ARTICLE
and X
7
3C
18 base pairs. The large substituent groups were in
either the trans- or gauche-conformations, minimizing steric
interactions. Two hydrogen bonds were predicted for the hydroxyl
groups of the HNE linkage (Figure 5). The O8H was predicted
to hydrogen bond with C
20 O
2, and O11H was predicted to
hydrogen bond with C
18 O
2.
Molecular Dynamics Simulations.Molecular dynamics simu-
lationsinexplicitsolventwerecarriedouttoassessthepotentialfor
hydrogen-bond formation involving the hydroxyl groups of the
HNE linkage. A fully solvated molecular dynamics simulation of
5nswascarriedoutstartingfromtherefinedstructureofthecross-
link (Figure S13 of the Supporting Information). The all-atom
mass-weightedroot-mean-squaredeviations(RMSDs)referenced
tothestartingstructureswereusedtocategorizetheconformation
of the trajectories. Two major conformers were observed for the
cross-link during the molecular dynamics simulations.
The MD trajectories were used to analyze the potential
hydrogen bonding of the carbinol hydroxyl group of the tether.
Table 3 lists the occupancies of the hydroxyl groups by the
potential hydrogen-bond acceptors in the MD trajectories. As
predicted by the reﬁned structures, irrespective of which con-
formation the cross-link adopted, the O8H predominantly
formed a hydrogen bond with C
20 O
2, and the O11H predomi-
nantly formed a hydrogen bond with C
18 O
2. The occupancies
involving hydrogen bonds with other receptors were negligible.
Watermoleculeswerenotinvolvedinthehydrogen-bondformation
with either of the hydroxyl groups throughout the simulations.
’DISCUSSION
DNAinterstrandcross-linksrepresent oneofthemostserious
types of DNA damage, because fundamental biological pro-
cesses, such as replication and transcription, require transitory
separation of the DNA strands. Findings that HNE, the major
in vivo peroxidation product of ω-6 polyunsaturated fatty acids,
1 3
induces DNA cross-linking
46 are consistent with cytotoxicity
induced by HNE.
54 Several signaling pathways, including heat
shock response activation, NF-kB inactivation, JNK activation,
and p53 target gene expression links to cell apoptosis, are
signiﬁcantly inﬂuenced by HNE.
12 DNA damage may also activate
the p53 damage response.
55 Additional interest in the cross-linking
abilities of the stereoisomers of HNE-derived 1,N
2-dG adducts
1 4arosefromstudiesofthecorresponding1,N
2-dGadductsof
acroleinandcrotonaldehyde,whichformedreversiblecross-links
in this 50-CpG-30 sequence, comprised of carbinolamine-type
linkages in equilibrium with trace amounts of imines.
56,57
Chemistry of HNE-Induced DNA Cross-linking. Kozekov
et al.
58,59 trapped a trimethylene cross-link upon insertion of
the acrolein-derived γ-OH-PdG adduct into this oligodeoxynu-
cleotide duplex at the 50-CpG-30 sequence by NaCNBH3
treatment. This implied the presence of the imine linkage, in
equilibrium with the carbinolamine linkage. Enzymatic digestion
of the cross-linked DNA afforded a cross-linked pyrimidopurinone,
58
Figure 5. Expanded view of the average structure of 10 reﬁned
structures of the cross-link from the minor groove. The aliphatic chain
ofHNEisnotshown.ThepredictedhydrogenbondsinvolvingtheHNE
hydroxyl groups are indicated with pink arrows.
Figure 6. Base pairing and base stacking of the cross-link at the cross-
linked region. The predicted hydrogen bonds are indicated by the pink
arrows.
Figure 7. (A) Conformation of the HNE linkage of the cross-link.
(B) Newman projections viewed along the C6 C7, C7 C8, and
C6 C11 bonds.
Table 3. Occupancies of Potential Hydrogen-Bonding
Interactions Involving the HNE Hydroxyl Groups in
Molecular Dynamics Simulations
hydrogen-bond receptors
a
donors C
6 O
2 A
8 N3 C
18 O
2 C
20 O
2 C
20 O40 solvent
O8H 1.2 0.0 0.0 98.0 0.1 0.1
O11H 0.0 0.6 99.4 0.0 0.0 0.0
aCriteriaforhydrogen-bondformation:distance<3.5Åandangle>120.16107 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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although it was not clear if the latter was also in equilibrium with
the carbinolamine and imine or if it was formed after the digestion.
In contrast,
1H 
15N HSQC NMR detected the presence of the
carbinolamine linkage,
60 as did
13C isotope-edited approaches.
61,62
Isotope-edited NMR has also been applied to characterizing the
chemistry of crotonaldehyde-mediated DNA cross-linking.
63
Because the carbinolamine, imine, and potentially the pyrimido-
purinone linkages exist in equilibrium (Scheme 1), monitoring
thecompositionofthemixturesinsituisofconsiderableinterest.
All three cross-linked species may contribute to the biological
processing of enals. The present studies apply isotope-edited
NMR to the chemistry of HNE-mediated DNA cross-linking in
the 50-CpG-30 sequence. The HNE adduct was synthesized with
a specific
13C-labelat the aldehyde carbon, which is position-8 of
the pyrmidopurinone structure 12. The strong
13C8fH8 corre-
lation observed in the
1H 
13C HSQC spectrum (Figure 2)
indicated that at equilibrium, one cross-linked species predomi-
nated. The identification of the carbinolamine linkage was
supported by observation of NOE correlations for HNE H8
with Y
19 H10,C
20 H10, and C
20 H40 (Figure 3), suggesting H8
oriented toward the complementary strand. The cross-link also
exhibited the H11fY
19 H10 NOE, suggesting that H11 oriented
inthesamedirectiontowardthecomplementarystrand.Astrong
HNE H8fHNE H11 NOE was observed (Figure 1). The
carbinolamine places both HNE H8 and HNE H11 toward the
complementary strand with a distance of less than 3 Å. The
carbinolamine cross-link 8 is expected to epimerize at the C8
carbon. The NOE data for the H8 proton indicate that the C8
carbon prefers the R-configuration.
The diastereomeric 1,N
2-dG adducts 1 and 3 rearrange to the
N
2-dG cyclic hemiacetals when placed into DNA.
44 It had been
hypothesizedthatthesigniﬁcantlevelsobserved forformationof
HNE-induced cross-links inthe50-CpG-30 DNA sequence could
be due to the presence of the corresponding tetrahydrofuran 11,
whichmightstabilizethecross-link.
43Thisdoesnotappear tobe
the case. The cyclic hemiacetal 6 derived from HNE adduct 1
exhibits a
3J(
13CfH) coupling for the C8 O C11 H11. The
carbinolaminecross-link8didnotexhibitthiscorrelation.Rather,
the strong H8fH11 NOE and failure to observe
3J (C8 O 
C11 H11) coupling suggested that the cross-link existed as
carbinolamine 8. Moreover, molecular modeling suggested that
the cyclic hemiacetal containing cross-link 11 placed the HNE
H8 and H11 in the trans conﬁguration, with H11 oriented
toward the 50-d(G
1C
2T
3A
4G
5C
6X
7A
8G
9T
10C
11C
12)-30 strand,
such that a strong H8fH11 NOE correlation should not have
been observed. Additionally, pyrimidopurinone linkage 12 has
been isolated by HPLC and characterized by mass spectrometry
when the cross-link is enzymatically digested.
43 However, the
presence of signiﬁcant equilibrium levels of either imine linkage
10 or pyrimidopurinone linkage 12 (Scheme 1) is excluded by
the observation of Y
19 N
2H and X
7 N1H protons, respectively.
Conformation of the Cross-link. The 3-carbon tether is too
short to span the guanines in the N
2-dG: N
2-dG cross-link,
forcing the cross-linked C
6
3Y
19 and X
7
3C
18 base pairs to tilt
toward each other (Figure 5). This has been observed for other
N
2-dG:N
2-dG cross-links bridged by three-carbon tethers.
62,64
The base stacking of C
6
3Y
19 with the 50-neighbor G
5
3C
20 is not
perturbed, whereas the base stacking of X
7
3C
18 with the 30-
neighbor A
8
3T
17 is perturbed (Figure 6). Despite the fact that
A
8
3T
17 is the 30-neighbor of the cross-linked base pairs, its
stabilityiscomparabletothatofotherA3Tbasepairs(Figure4).
The gauche conformations of the HNE C6 and C8 carbons with
respect to the cross-linked guanine N
2 amines facilitate Watson -
Crickhydrogenbondingofthecross-linkedC
6
3Y
19andX
7
3C
18base
pairs (Figure 7). This has also been observed with other N
2-dG:N
2-
dG cross-links.
62,64 66 The HNE linkage adopts a low energy
conformation by placing all of the substituent groups in either trans-
or gauche-orientations (Figure 7). The small cross peaks assigned to
the C
6 H10fX
7 H8 and C
18 H10fY
19 H8 correlations were
observed for other cross-links in the 50-CpG-30 sequence that were
bridged by the trimethylene,
67,68 R-methyltrimethyl,
64 or the
carbinolamine derived from the acrolein 1,N
2-dG adduct.
62
The stabilization of (6S,8R,11S) carbinolamine cross-link
43 8
appears to be mediated by hydrogen-bonding interactions. The
solvated equilibrium molecular dynamics simulations predict
hydrogen bonds between O8H and C
20 O
2, and between O11H
and C
18 O
2 (Figure 5). In contrast, the (6S,8S,11S) carbinola-
mine cross-link, which is not observed, would have placed the
O8H in a gauche-conﬁguration with respect to C6, and the
O8HfC
20 O
2 hydrogen bond would not be possible. Thus, it
seemsplausiblethattheO8HfC
20O
2 hydrogen bondstabilizes
the carbinolamine linkage and accounts for the stereoselectivity
of cross-linking, favoring the (6S,8R,11S) cross-link 8. As well,
formation of a O11HfC
18 O
2 hydrogen bond further stabilizes
the(6S,8R,11S)carbinolaminecross-link.Thesehydrogenbonds
may also explain why carbinolamine cross-link 8 does not exist as
the tetrahydrofuran 11, as the removal of two these hydroxyl
groups and their hydrogen-bonding capabilities with the DNA
would disfavor the latter.
Comparison with Acrolein- and Crotonaldehyde-Derived
Cross-links.Theacrolein-derived1,N
2-dGadductalsoinducesa
N
2-dG:N
2-dG cross-link in the 50-CpG-30 sequence,
58,59 as do
thetwodiastereomericcrotonaldehyde-derived1,N
2-dGadducts.
59,63
These cross-links exist predominantly as carbinolamine linkages
for both acrolein and crotonaldehyde adducts. The acrolein
cross-link favors the R-carbinolamine linkage, but the S-carbino-
lamine linkage is detectable by NMR.
62 The structure of the
cross-link indicates that base stacking of the cross-linked base
pair with the 30-flanking base pair is not affected by the cross-
linking. This is consistent with the trimethylene N
2-dG:N
2-dG
cross-link, which has been used as a model.
62 Similarly, a hydrogen
bond involving the carbinol hydroxyl group with the 50-flanking
cytosineO
2ispredictedtostabilizethecross-linkandaccountfor
the stereoselectivity.
62 The R-isomer of the crotonaldehyde
adduct at the C6 position forms the cross-link more efficiently
than does the S-isomer.
59 Significantly, the 6R-isomer of the
crotonaldehyde adduct has the same relative configuration
as does the (6S,8R,11S) HNE adduct 1. The stereoisomeric
R-methyltrimethylene cross-links have been used as surrogates
for these carbinolamine cross-links.
64 The S-CH3 group inter-
feres with the 30-flanking base pair, whereas the R-CH3 group
does not. As compared to the crotonaldehyde R-CH3 group, the
30-oriented HNE aliphatic chain has greater influence on the
30-flanking base pair. Poor base stacking was observed between
X
7
3C
18 and A
8
3T
17 base pairs (Figure 6).
Biological Implications. In humans, DNA cross-link repair
requires the cooperation of multiple proteins belonging to different
biological pathways, including, but not limited to, nucleotide
excision repair, homologous recombination, translesion DNA
synthesis, double-strand break repair, and the Fanconi anemia
pathway.
54,69 73 Current models suggest that cross-link repair is
initiated bydualincisions around the cross-linkinoneof the two
affected strands. This “unhooking”depends on the endonucleolytic
activity ofthe XPF/ERCC1 complex,acomponentof NER. The16108 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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result is a gap that may be filled by pairing of the 30-terminus of
the preincised strand with the homologous sequence, followed
by DNA synthesis. Alternatively, the complementary strand with
the cross-link attached may be used as a template for translesion
DNA synthesis. Once the integrity of one DNA strand is restored,
the second strand may be repaired by conventional NER. When
repair is concomitant with replication, a DNA double-strand
break is formed; thus, additional biological processing would be
required to tolerate interstrand cross-links.
54,70
Because enal-mediated cross-links are reversible, prior studies
have utilized the fully reduced trimethylene N
2-dG:N
2-dG cross-
linksasmodelstoaddressmolecularmechanismsofrepair.Arole
for XPF/ERCC1 heterodimer in the processing of a double
strand break (DSB) was created when the saturated cross-link
encounters the replication fork.
74 It has been proposed that the
cross-link repair is initiated by NER followed by trans-lesion
DNA synthesis (TLS) and completed through another round of
NER in E. coli.
75 Liu et al.
76 examined the repair of crotonalde-
hyde-derived N
2-dG:N
2-dG cross-links following replication of
site-speciﬁcally modiﬁed vectors in E. coli and mammalian cells.
Their results suggest that the native cross-link partially reverts
and are consistent with reports that NER is essential for repair in
E. coli.
77,78 In XPA cells, the reduced cross-link is removed,
suggesting a repair pathway unique to higher eukaryotes that
does not require damage recognition by NER.
76 Minko et al.
79
reported that a vector containing a model of the incised product
following dual incision around the saturated N
2-dG:N
2-dG
trimethylene cross-link is replicated in mammalian cells. Human
polymerase k catalyzes accurate incorporation opposite this
cross-link and also elongates the sequence. The reversibility of
the HNE derived cross-links, noted by Liu et al.,
35 might reduce
their abilities to block DNA processing, in vivo. Cross-link
reversion would be anticipated to target removal of the resulting
bulky N
2-dG adducts by NER.
80 82
In light of the observation that the (6S,8R,11S) HNE-derived
adduct 1 forms cross-links in 50-CpG-30 DNA sequences in
vitro,
42,43 it is anticipated that the cross-linking will also occur
in vivo. Cross-links were observed at levels of 1 2% that of the
uncross-linked adduct when calf thymus DNA was treated with
acrolein and HNE,
83 and it will be of interest to search for this
reversible HNE-derivedcross-link incellularDNA. Becausethey
occur speciﬁcally at 50-CpG-30 sequences, and only for (6S,8R,11S)
HNE adduct 1, they are anticipated to be present at low levels
invivo,challengingthelimitsofdetectionbymassspectrometry.On
the other hand, the genotoxic and cytotoxic consequences arising
fromlowlevelsofthiscross-linkmaybeofconsiderablesigniﬁcance.
’SUMMARY
HNE-derived (6R,8S,11R)1 , N
2-dG adduct 1 produces the
(6R,8S,11R) carbinolamine cross-link 8 in the 50-CpG-30 DNA
sequence. The HNE moiety is located in the minor groove.
Hydrogen bonds between O8H and C
20 O
2 and between O11H
and C
18 O
2 are predicted to stabilize cross-link formation. They
arealsoproposedtoaccountforthestereoselectivityandresultin
the higher yield by HNE adduct as compared to acrolein and
crotonaldehyde adducts.
’EXPERIMENTAL SECTION
Materials. The oligodeoxynucleotide 50-GGACTCGCTAGC-30
was synthesized and purified by anion-exchange chromatography by
the Midland Certified Reagent Co. (Midland, TX). The oligodeoxynu-
cleotidescontainingHNEderived(6S,8R,11S)1,N
2-dGadducts1inthe
dodecamer 50-d(GCTAGCXAGTCC)-30, where X represents the HNE
adduct, were synthesized, purified, and characterized as reported.
42,43
The purities of the adducted oligodeoxynucleotides were assessed
by capillary gel electrophoresis and HPLC. Oligodeoxynucleotides
were desalted by chromatography on Sephadex G-25. The synthesis
of isotope-labeled oligodeoxynucleotides is described in the Supporting
Information.
Preparation of the Cross-link. The oligodeoxynucleotide 50-
d(GCTAGCXAGTCC)-30 containingHNEadduct1wasannealedwith
the complementary strand 50-d(GGACTCGCTAGC)-30 in buffer con-
taining 10 mM NaH2PO4, 100 mM NaCl, and 50 μMN a 2EDTA
(pH 7.0). The solution was heated to 95 C for 10 min, then slowly
cooled to room temperature. The duplex was purified by DNA grade
hydroxylapatite chromatography with a gradient from 10 to 200 mM
NaH2PO4 in 100 mM NaCl, 50 μMN a 2EDTA (pH 7.0), and then
desalted usingSephadexG-25.Theduplexwasthendissolvedin10mM
NaH2PO4,100mMNaCl,and50μMNa 2EDTA(pH7.0).ThepHwas
adjusted to 7.3. The sample was maintained at 37 C for 3 months. The
cross-linking was monitored by observing the cytosine H5 H6 scalar
couplings by NMR. After 3 months, the sample was used for NMR experi-
mentswithoutfurtherpurification.HPLCanalysissuggestedtheduplexwas
>75% cross-linked. The MALDI-TOF mass spectrometry showed
the cross-link at m/z of 7428.2 [calculated for imine cross-link 10
(M   1): 7429.0].
NMR. Samples were at 1.0 mM strand concentration. Samples for
observation of nonexchangeable protons were dissolved in 280 μLo f
buffer containing 10 mM NaH2PO4, 100 mM NaCl, and 50 mM
Na2EDTA (pH 7.0). They were exchanged with D2O and suspended
in 280 μL of 99.996% D2O. The pH was adjusted to 7.3 with dilute DCl
or NaOD. Samples for the observation of exchangeable protons were
dissolved in 280 μL of 10 mM NaH2PO4, 100 mM NaCl, and 50 μM
Na2EDTA, (pH 7.0) containing 9:1 H2O:D2O (v/v), and the pH was
adjusted to 7.3.
1H 
13C HSQC and
1H 
13C HMBC experiments
experiments
76 78 were performed on a Bruker Avance 500 spectro-
meter. Other NMR experiments were performed on a Bruker Avance
800 spectrometer. The temperature was 25 C for observation of the
nonexchangeable protons and 5 C for observation of the exchangeable
protons. Chemical shifts for
1H were referenced to water. Chemical
shiftsfor
13Cwerenotcalibrated.DatawereprocessedusingTOPSPIN,
and the assignments were made using SPARKY.
84 For all NMR
experiments, a relaxation delay of 1.5 s was used. Two-dimensional
homonuclear NMR spectra were recorded with 512 real data in the t1
dimension and 2048 real data in the t2 dimension.
1H 
1H NOESY
spectra were zero-filled during processing to create a matrix of 1024  
1024 real points. A skewed sinebell-square apodization with 15 phase
shiftwasusedinbothdimensionstoprocess
1H 
1HCOSYspectra.The
1H 
1HTOCSYmixingtimewas80ms.Forassignmentofexchangeable
protons,
1H 
1H NOESY experiments used the Watergate sequence.
85
The mixing time was 250 ms. For assignment of nonexchangeable
protons and the derivation of distance restraints,
1H 
1H NOESY
experiments used TPPI quadrature detection, and mixing times of 60
and 250 ms were used.
1H 
1H DQF-COSY experiments were per-
formedwithTPPIquadraturedetectionandpresaturationoftheresidual
water during the relaxation delay.
1H 
13C HSQC experiments were
carriedoutusingstandard
1H-detectedpulseprogramswithStates-TPPI
phase cycling.
86 88 The spectra were recorded with 256 real data in the
t1dimensionand1024realdatainthet2dimensionandwerezerofilled
to create a matrix of 1024   1024 real points.
1H 
13C HMBC
experiments used the low phase J-filter to suppress
1J couplings. The
spectra were recorded with 256 real data in the t1 dimension and 1024
real data in the t2 dimension and were zero filled to create a matrix of
1024   1024 real points.16109 dx.doi.org/10.1021/ja205145q |J. Am. Chem. Soc. 2011, 133, 16101–16110
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Molecular Dynamics. Restrained molecular dynamics (rMD)
calculations
51,89 for similar modified oligodeoxynucleotide duplexes
havebeendescribed.
44,46,90NOE-deriveddistancesfromcrosspeakvolumes
measured at mixing 250 ms were calculated using MARDIGRAS.
91
Empirical restraints preserved Watson Crick hydrogen bonding and
prevented propeller twisting between base pairs. The duplex was found
tomaintainaB-typeDNAconformation;exceptforthecross-linkedand
the terminal base pairs, the backbone and sugar pucker torsion angle
restraints were using empirical data derived from B-DNA.
50 The car-
binolaminecross-linkwasconstructedusingtheprogramInsightII.The
rMD calculations
51,89 were conducted with the AMBER parm99 force
field.
92 The generalized Born (GB) model
93 with parameters developed
by Tsui andCase
94 was used for implicit water simulation. Theprogram
CORMA
51was utilizedto estimatetheNOEintensitiesfromthestructures
refinedfromrMDcalculations.Helicoidalanalyseswerecarriedoutwith
3DNA.
95
Molecular dynamics simulations in explicit water were performed
usingtheAMBERforceﬁeld
92withtheparticlemeshEwald
96,97(PME)
method. The reﬁned structure converged from the rMD calculation was
usedasthestartingstructure.Thecross-linkwassurroundedbyan8.0Å
cubic TIP3P water box in each direction. A total of 22 Na
+ ions were
added to neutralize the duplex. The cutoﬀ radius for nonbonding
interactions was 8.0 Å. Bond lengths involving hydrogens were ﬁxed
with the SHAKE algorithm. The cross-link was ﬁrst energy-minimized
for1000interations.Themoleculardynamicssimulationwascarriedout
with constant volume at 300 K for 10000 iterations with an integrator
timeof1fs.Themoleculardynamicssimulationatconstantpressurewas
performed at 300 K for 5 ns with an integrator time of 1 fs. The PTRAJ
module from the AMBER 10 package was used to analyze the trajec-
tories.Thermsdvaluesofthetrajectorieswerereferencedtothestarting
structure. A distance of less than 3.5 Å and an angle of greater than 120
betweenthepotentialhydrogendonorandacceptorwereusedascriteria
for hydrogen-bond formation.
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